title: [Diclofenac sodium therapy in irritating micturition syndrome following TUR for benign prostatic hyperplasia].
abstract: The irritative micturition syndrome is commonly observed following endoscopic surgery for benign prostatic hyperplasia. This condition almost consistently presents following removal of the bladder catheter and may last from 15 to 45 days. The present study was undertaken to determine the efficacy of treatment with diclofenac sodium. Fifty patients submitted to endoscopic resection for benign prostatic hyperplasia received the agent IM a few hours prior to catheter removal and posteriorly via the rectal route for a total treatment period of 13 days. Good results were achieved in 95.5% of the cases. Mild side effects were observed in 14% of the patients.
authors.affiliation: Servicio de Urología, Ciudad Sanitaria Vall d'Hebron, Barcelona, España.
authors.forename: A
authors.initials: A
authors.lastname: Soler Roselló
authors.forename: J
authors.initials: J
authors.lastname: Morote Robles
authors.forename: D
authors.initials: D
authors.lastname: García Rojo
authors.forename: J
authors.initials: J
authors.lastname: Vila Barja
authors.forename: A
authors.initials: A
authors.lastname: Prera Vilaseca
mesh_terms: D004008:Diclofenac / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011182:Postoperative Care; D011183:Postoperative Complications / Q000188:drug therapy; D011468:Prostatectomy / Q000379:methods*; D011470:Prostatic Hyperplasia / Q000188:drug therapy / Q000601:surgery*; D014555:Urination Disorders / Q000188:drug therapy*
chemical_list: D004008:Diclofenac
vernacular_title: Tratamiento con diclofenaco sódico del síndrome miccional irritativo tras resección transuretral por hiperplasia prostática benigna.